Related Experiment Video
Updated: Jun 23, 2025

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
Published on: February 24, 2023
Prognostic Factors for Recurrent Glioma: A Population-Based Analysis
Pengfei Fu1,2,3,4,5, Jingjing Shen6, Kun Song1,2,3,4,5
1Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Identifying World Health Organization (WHO) grade and gliosis percentage as key prognostic factors, this study developed a nomogram to predict outcomes for recurrent glioma patients. This tool aids in stratifying patients into high- and low-risk groups for personalized treatment decisions.
Area of Science:
- Neuro-oncology
- Cancer Prognostics
- Radiotherapy
Background:
- Recurrent glioma presents a significant challenge with poor overall survival (OS).
- The roles of radionecrosis and prognostic factors in recurrent glioma remain debated.
- Effective predictive models are crucial for guiding clinical management.
Purpose of the Study:
- To identify independent prognostic factors for recurrent glioma after radiotherapy.
- To develop and validate a nomogram for predicting recurrent glioma risk and prognosis.
- To stratify patients into distinct risk groups for improved clinical decision-making.
Main Methods:
- Screening of recurrent glioma patients who received radiotherapy and surgery.
- Univariate and multivariate Cox regression analyses to determine prognostic factors.
- Construction and validation of a nomogram using C-index, ROC analysis, DCA, and Kaplan-Meier curves.
Main Results:
- World Health Organization (WHO) grade and gliosis percentage were identified as independent prognostic factors.
- The nomogram demonstrated high predictive performance with a C-index of 0.682.
- Patients were successfully stratified into low-risk and high-risk groups based on overall survival.
Conclusions:
- WHO grade and gliosis percentage are significant prognostic factors for recurrent glioma with radionecrosis.
- A validated nomogram based on these factors can visually predict patient prognosis.
- This model facilitates individualized clinical decisions and risk stratification for recurrent glioma patients.
More Related Videos
10:58Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
05:45Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017